Overcoming Pharmaceutical Supply Chain Risks with AI Tools, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into the most critical issues faced by pharmaceutical supply chains and how to address...
Pharmaceutical
Catalyx Report Reveals Persistent Manufacturing Bottlenecks in Life Sciences Industry
Despite Digital Technology Push, Nearly Two-Thirds of Pharmaceutical and Medical Device Companies Still Rely on Manual Processes for Critical Production...
Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones
MESA, ARIZONA / ACCESS Newswire / November 25, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today confirmed that it...
Mann Eye Institute Announces Its Holiday Luxury Showcase: An Exclusive Evening of Designer Eyewear
HOUSTON, TEXAS / ACCESS Newswire / November 25, 2025 / Mann Eye Institute is kicking off the season in style...
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
Live webcast fireside chat on Thursday, December 4th at 10:30 AM ET Carlsbad, CA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Palisade...
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of...
VSee Health’s iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine...
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related...
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
UniDoc Receives Order for Health Cubes
Three units for demonstration within Verizon Innovation Labs VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / UniDoc Health...
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will...
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
As UnitedHealthcare Scales Back Traditional RPM, Addison(R) Virtual Caregiver Signals the Next Phase of Home-Based Care
Electronic Caregiver's 24/7 virtual caregiving platform steps forward just as payers move away from low-engagement, device-only monitoring. LAS CRUCES, NM...
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to...
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif.,...
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing...
Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
WAYNE, Pa., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
Compass Therapeutics to Participate in Upcoming December Investor Events
BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
CytomX Therapeutics to Present at Upcoming December Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...